Covidien COV, a leading global provider of healthcare products and
recognized innovator in patient monitoring and respiratory care devices, today
announced U.S. Food and Drug Administration 510(k) clearance and European
Economic Area (EEA) CE Mark approval for the Covidien Nellcor^™ Bedside
Respiratory Patient Monitoring system.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in